+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review



Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review



Journal of Neurology 260(11): 2701-2714



Motor complications in Parkinson's disease (PD) result from the short half-life and irregular plasma fluctuations of oral levodopa. When strategies of providing more continuous dopaminergic stimulation by adjusting oral medication fail, patients may be candidates for one of three device-aided therapies: deep brain stimulation (DBS), continuous subcutaneous apomorphine infusion, or continuous duodenal/jejunal levodopa/carbidopa pump infusion (DLI). These therapies differ in their invasiveness, side-effect profile, and the need for nursing care. So far, very few comparative studies have evaluated the efficacy of the three device-aided therapies for specific motor problems in advanced PD. As a result, neurologists currently lack guidance as to which therapy could be most appropriate for a particular PD patient. A group of experts knowledgeable in all three therapies reviewed the currently available literature for each treatment and identified variables of clinical relevance for choosing one of the three options such as type of motor problems, age, and cognitive and psychiatric status. For each scenario, pragmatic and (if available) evidence-based recommendations are provided as to which patients could be candidates for either DBS, DLI, or subcutaneous apomorphine.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055690522

Download citation: RISBibTeXText

PMID: 23287972

DOI: 10.1007/s00415-012-6798-6


Related references

Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion. Febs Journal 275(7): 1370-1376, 2008

Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Parkinsonism and Related Disorders 15(10): 728-741, 2010

Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease. Clinical Neuropharmacology 40(3): 103-107, 2017

A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. Journal of Neurology 258(4): 579-585, 2011

Review of the economic evidence on the use of deep brain stimulation in late stage Parkinson's disease. Neurologia 24(4): 220-229, 2010

Deep brain stimulation for Parkinson's disease and other movement disorders: an evidence-based analysis. Ontario Health Technology Assessment Series 5(2): 1-56, 2005

The Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease (CAPSIT-PD): Tolerability of Preoperative Neuropsychological Testing for Deep Brain Stimulation in Parkinson's Disease. Movement Disorders Clinical Practice 2(4): 379-383, 2015

Deep brain stimulation in Parkinson's disease: reconciliation of evidence-based medicine with clinical practice. Lancet. Neurology 12(1): 25-26, 2013

Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a therapy approaching evidence-based standards. Journal of Neurology 250 Suppl 1: I43-I46, 2003

Substituting the Target After Unsatisfactory Outcome of Deep Brain Stimulation in Advanced Parkinson's Disease: Cases From the NSTAPS Trial and Systematic Review of the Literature. Neuromodulation 21(6): 527-531, 2017

Systems approaches to optimizing deep brain stimulation therapies in Parkinson's disease. Wiley Interdisciplinary Reviews. Systems Biology and Medicine 2018: E1421, 2018

Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease. Parkinsonism and Related Disorders 13 Suppl: S18-S23, 2007

Deep brain stimulation for advanced Parkinson's disease. Aorn Journal 72(3): 387-90, 393-408; Quiz 409-14, 416-8, 2000

Deep brain stimulation for advanced Parkinson's disease. Lancet. Neurology 9(6): 558-559, 2010

Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing. Geriatric Nursing 37(6): 434-439, 2016